Dear Reader, This week, I attended the unusual event where I sat on an expert panel to judge a stock idea with 25x upside potential... And to give my opinion on the genius hedge-fund veteran presenting the idea, who – spoiler alert – is going to be a kind of standard-bearer for all of MarketWise (the parent company of Stansberry Research, Chaikin Analytics, and other business affiliates) from this moment forward. If you're familiar with the TV show Shark Tank, the setup here was broadly similar... For a short time longer, you can still view a complete replay – including the exact name and ticker of the 25x-potential stock idea – right here. As you'll see, I voted "yes" – I would put money into this idea. And so did some other judges whose track records and literal decades of market experience I have the utmost respect for. In fact, far beyond the money you could make from this one stock idea... This event details the biggest moneymaking opportunity I can ever remember seeing across more than four decades in the market. And I believe you will regret it if you don't see it and take action this week. You'll kick yourself if you're "on the sidelines" looking in at what's about to happen. You don't have to take my word for it... Everything about this (highly unusual) event is designed to give you everything you need to decide for yourself. My best advice is to drop everything and take a look at this right now because it won't be available for long. Now, I also wanted to share one more thing that may interest you... It's something absolutely no one who wasn't on set that day has ever seen. It had to be cut from the presentation in the interest of time. It's my candid feedback about the man who made nine-figure market gains at two different elite hedge funds... And who has now quit working for billionaires... To share his strategy (targeting 300% to 500% on every position) exclusively with readers like you from now on. You can take a look at those comments below. Here's to our health, wealth, and a great retirement, Dr. David Eifrig, MD, MBA
Senior Partner, Stansberry Research
CEO, MarketWise P.S. Here are the comments I shared with our event host and the other experts on the panel – top Stansberry analyst and hedge-fund veteran Whitney Tilson... quantitative genius Marc Chaikin, founder of Chaikin Analytics... and Louis Navellier of InvestorPlace, the legend behind hundreds of triple- and quadruple-digit winning max gains. The "secret weapon" who had just presented his idea – hedge-fund vet Gabe Marshank – had already left the set – so this was pretty candid: Sure, I'll be happy to wrap this up, Amy. It's actually hard to add to what the others have already said so well. But there are a few things that I can add that are unique because of my position... I've been around financial newsletters for a very long time, as an analyst... as a partner in the business... and now as the CEO of MarketWise, which is the parent company to Stansberry Research and the other businesses represented in this room. And that means I'm ultimately responsible for who represents us. In terms of hiring. In terms of the research we publish. And even sometimes having to make the hard decisions to shut something down. I'm certainly not afraid to say that I think even bringing Gabe on board has been an incredible catch. Last fall, he was giving a presentation at an internal company event in Washington, D.C., and I was sitting there literally texting other senior folks in the room saying, "We have to get this guy out in front of readers, and we have to do it now." It was so obvious to me that I thought he would be great for our subscribers. He was a natural teacher and a great speaker. I pressed him at dinner that night and the next couple of days. We even hired him to do some more teaching and educating about his investing strategies to a monthly analyst group, and it was spectacular. So here we are... Everything he's done since arriving has borne that out. I've only been CEO for about a year, and frankly, I'd like to think that if I were in that role earlier, he would already have his own research letter. I'm thrilled that that's finally happening. And if you're seeing this, you're very, very lucky. Because you're going to have the only opportunity, ever, to be a part of this flagship new research from the beginning. Which means the potential for market gains will move in your favor. And also means you're in the only group that will ever see this research priced the same way we price our existing high-end research. After this, it's going to be on a tier of its own, with higher pricing.
Given the last part of my comments, I want to be completely candid and upfront with you: Gabe Marshank's research will cost $10,000 per year for a subscription – by far the most we've ever charged for standalone research across any of our affiliates. That won't change. In fact, it will only likely go up. I have zero doubt this new research is worth that amount and more. But this week is a one-time-only "charter membership" period where the terms are completely different. It is the one and only time we will EVER offer this pricing... including more than $14,000 worth of research and included bonuses for an 82% total discount. The only way to claim that discount is to go here before this one-time charter membership period – for the very first new subscribers – expires forever. | 
No comments:
Post a Comment
Keep a civil tongue.